医学
糖尿病
疾病
重症监护医学
内科学
糖皮质激素
流行病学
肾脏疾病
胰岛素抵抗
内分泌学
2型糖尿病
库欣病
临床试验
地塞米松
2型糖尿病
诊断试验
胰岛素
前瞻性队列研究
肾上腺功能不全
氢化可的松
生物信息学
梅德林
病理生理学
库欣综合征
血管疾病
地塞米松抑制试验
治疗方法
临床研究
作者
Muhammad Shahzeb Khan,Muhammad Sameer Arshad,Deepak L. Bhatt,David Z.I. Cherney,Ralph A. DeFronzo,Jennifer B. Green,Yehuda Handelsman,Tariq Shafi,Jeffrey Moore Testani,Javed Butler
标识
DOI:10.1093/eurheartj/ehag827
摘要
Despite guideline-directed therapy, many patients with cardio-kidney-metabolic (CKM) disease remain uncontrolled due to therapeutic inertia, adherence barriers, and underrecognized secondary causes. Hypercortisolism, ranging from mild autonomous cortisol secretion (MACS) to overt Cushing syndrome, is an increasingly recognized contributor. MACS is associated with a 2.5-fold higher risk of cardiovascular death and increased prevalence of hypertension, type 2 diabetes mellitus (T2DM), and kidney impairment. Cortisol excess promotes muscle insulin resistance, hepatic gluconeogenesis, β-cell dysfunction, sodium retention, and vascular remodelling, worsening glycaemia and blood pressure, leading to poor CKM outcomes. Recent prospective studies suggest that hypercortisolism is more prevalent than previously suspected in selected CKM phenotypes, including 24% in patients with difficult-to-control T2DM in CATALYST and 27% in patients with resistant hypertension in MOMENTUM. The overnight 1 mg dexamethasone suppression test remains the diagnostic test of choice. Therapeutic strategies include adrenal steroidogenesis inhibitors, glucocorticoid receptor antagonists, and pituitary-directed therapies in selected cases, while surgery remains the first-line treatment for surgically remediable disease. This review summarizes the epidemiology and mechanisms linking cortisol excess to CKM dysfunction, and also highlights the need for clinical trials, standardized diagnostic thresholds, and assays to enable integration of cortisol-targeted therapies into management pathways to mitigate residual CKM risk. This review will serve as a practical guide for cardiologists to manage a potentially reversible contributor to poor CKM control.
科研通智能强力驱动
Strongly Powered by AbleSci AI